Antiresorptive Agents

Aromatase inhibitors (AIs) are the preferred therapy for postmenopausal women with early-stage estrogen receptor-positive breast… (More)

Several case reports and small case series have suggested a higher incidence of medication-related osteonecrosis of the jaw… (More)

INTRODUCTION The existing medications approved for treatment of primary osteoporosis can be divided into antiresorptive drugs and… (More)

No well-established evidence supporting safe use of bisphosphonates (BPs) or other antiresorptive agents prior, during, or after… (More)

Primary biliary cirrhosis (PBC) is a liver-specific autoimmune disease that primarily affects women (female-to-male ratio, 10:1… (More)

AIMS The primary objective was to assess the occurrence rate of Medication-Related OsteoNecrosis of the Jaw (MRONJ) after dental… (More)

Management of osteonecrosis of the jaw associated with antiresorptive agents is challenging, and outcomes are unpredictable. The… (More)

2-(Trimethylammonium) ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate [(R)-TEMOSPho], a derivative of an organic chemical… (More)

BACKGROUND Bone resorption inhibitor-related osteopathology of the jaw (BRIOJ) is a severe complication in patients treated with… (More)

This is the seventh article in the series of Clinical Updates on Nursing Home Care. The topics covered are antiresorptive drugs… (More)